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Survivin is an inhibitor of apoptosis family protein
implicated in apoptosis and mitosis. In apoptosis, it
has been shown to recognize the Smac/DIABLO
protein. It is also a component of the chromosomal
passenger complex, a key player during mitosis.
Recently, Survivin was identified in vitro and in vivo
as the direct binding partner for phosphorylated
Thr3 on histone H3 (H3T3ph). We have undertaken
structural and binding studies to investigate the
molecular basis underlying recognition of H3T3ph
and Smac/DIABLO N-terminal peptides by Survivin.
Our crystallographic studies establish recognition
of N-terminal Ala in both complexes and identify
intermolecular hydrogen-bonding interactions in the
Survivin phosphate-binding pocket that contribute
to H3T3ph mark recognition. In addition, our calori-
metric data establish that Survivin binds tighter
to the H3T3ph-containing peptide relative to the
N-terminal Smac/DIABLO peptide, and this prefer-
ence can be reversed through structure-guided
mutations that increase the hydrophobicity of the
phosphate-binding pocket.
INTRODUCTION
Human Survivin was originally identified as an anti-apoptotic
protein, which is overexpressed in most human tumors and
fetal tissue, but not in terminal differentiated cells (Ambrosini
et al., 1997; Reed, 2001; Sah et al., 2006). It is a small protein
(142 residues), belonging to the inhibitor of apoptosis (IAP)
protein family (Salvesen and Duckett, 2002). The IAP protein
family shares a common baculovirus IAP repeat (BIR) domain,
which is usually located at the N-terminus of the protein
(Srinivasula and Ashwell, 2008). The BIR domain functions as
a mediator for protein-protein interactions through utilization
of a deep surface peptide-binding groove to recognize the
conserved N-terminal Ala-containing IAP-binding motif (IBM)
of the target protein. A well-studied, published example
involves the recognition of N-terminus Smac/DIABLO (SmacN)
IBM by the BIR3 domain of XIAP, in which the N-terminal Ala of
Smac inserts into a deep surface pocket of BIR3, with complex
formation mediated by extensive intermolecular interactionsStructure 20, 185(Liu et al., 2000; Wu et al., 2000). Although Survivin contains
the BIR domain, the role of Survivin in the apoptotic pathway
remains to be elucidated (Lens et al., 2006; Yue et al., 2008).
One suggested mechanism has proposed that Survivin can
bind to Smac, thereby neutralizing the inhibition of XIAP by
Smac (Song et al., 2003). Binding of Survivin to Smac has
been monitored by nuclear magnetic resonance (NMR) with
the mapped binding surface overlapping with a region corre-
sponding to the Smac binding site on BIR3 of XIAP (Sun
et al., 2005).
It has been established that Survivin plays multiple, essential
roles during mitosis and meiosis as a subunit of the chromo-
somal passenger complex (CPC), which is enriched on the
centromere in early M phase but is relocated to the spindle
midzone in anaphase (Ruchaud et al., 2007). The CPC contains
two distinct modules—a kinase subcomplex domain composed
of the Aurora B kinase and the C-terminal fragment of the inner
centromere protein (INCENP)—and a chromosomal localization
subcomplex composed of the N-terminal fragment of INCENP,
Survivin and Borealin (Kelly et al., 2007). Further studies have
established that Survivin was the CPC component responsible
for direct binding of histone H3 phosphorylated at Thr3
(H3T3ph), thereby recruiting CPC to mitotic chromatin during
mitosis (Kelly et al., 2010; Wang et al., 2010; Yamagishi et al.,
2010). Such recruitment results in the activation of the Aurora
B kinase, which can promote spindle assembly and inhibit
nuclear reformation (Kelly et al., 2010), and contributes to
regulation of the spindle assembly checkpoint and kineto-
chore-microtubule attachment (Wang et al., 2010; Yamagishi
et al., 2010).
Survivin has been shown to be overexpressed in most cancer
cells but not normal terminal differentiated tissues (Ambrosini
et al., 1997; Reed, 2001; Sah et al., 2006), and downregulation
of Survivin expression and/or its functions can sensitize tumor
cells to therapeutics (Kanwar et al., 2010a). Thus, Survivin is
a promising drug target against cancer, as well as a biomarker
for angiogenesis and cancer diagnosis (Kanwar et al., 2010a,
2010b; Pennati et al., 2008; Ryan et al., 2009). Crystal structures
are available for both human and mouse Survivin in the free
state (Chantalat et al., 2000; Muchmore et al., 2000; Verdecia
et al., 2000). Structurally, human Survivin is composed of an
N-terminal BIR domain and a C-terminal long a-helix, with the
latter shown structurally to form an intermolecular three-helix
bundle with the N-terminal fragment of INCENP and Borealin
(Jeyaprakash et al., 2007). NMR chemical shift mapping studies
have shown that the N-terminal BIR domain of Survivin forms
a complex with the N-terminal peptide of Smac/DIABLO–195, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 185
Table 1. Summary of Diffraction Data and Structure Refinement
Statistics of H3(1-10) and H3(1-15)T3ph Peptide Complexes with
Wild-Type Survivin and Survivin(K62Y/H80W) Double Mutant
Summary of Diffraction Data
Crystal
H3(1–15)T3ph-
Survivin
H3(1–10)-
Survivin
H3(1–10)
Survivin
(K62Y/H80W)
PDB code 3UIG 3UII 3UIK
Beamline APS-24ID-C APS-24ID-E APS-24ID-E
Wavelength (A˚) 0.9795 0.9792 0.9792
Space group C2 C2 C2
Cell parameters
a (A˚) 115.8 115.3 114.8
b (A˚) 71.0 71.3 71.0
c (A˚) 82.3 81.6 81.6
b () 128.8 128.5 129.3
Resolution (A˚) 50.0-2.4
(2.49-2.40)a
50.0-2.6
(2.69-2.60)
30.0-2.7
(2.80-2.70)
Rmerge (%) 5.2 (52.7) 8.6 (52.9) 7.4 (64.0)
Observed reflections 82,484 66,350 50,310
Unique reflections 20,244 16,412 13,470
Redundancy 4.1 (3.9) 4.0 (3.9) 3.7 (3.5)
Average I/s(I) 17.2 (2.0) 10.1 (2.0) 31.4 (1.8)
Completeness (%) 97.9 (86.9) 98.9 (96.4) 96.6 (83.6)
Refinement and Structure Model
R / R free 21.3 / 25.0 22.2 / 27.3 21.9 / 28.1
Number of atoms 2,329 2,293 2290
Protein / Peptide 2,215 / 90 2,210 / 64 2224 / 64
Water 22 17 –
Zn2+ ion 2 2 2
Average B factor (A˚2) 96.3 89.1 119.6
Protien / Peptide 95.9 / 110.0 88.4 / 115.1 118.2 / 169.1
Water 85.5 82.3 –
Zn2+ ion 73.0 76.5 98.6
RMS deviations
Bond lengths (A˚) 0.010 0.013 0.010
Bond angles () 1.224 1.430 1.408
a Values in parentheses are for highest resolution shell.
Structure
H3T3ph and SmacN Peptides Recognition by Survivin(Sun et al., 2005) and with the N-terminal H3T3ph (Kelly et al.,
2010) peptides. Nevertheless, these studies have not identified
the detailed intermolecular contacts associated with molecular
recognition on complex formation. We report below on crystal
structures of human Survivin in complex with unmodified H3,
H3T3ph-containing and SmacN peptides, as well as isothermal
titration calorimetry (ITC)-based studies on the wild-type
complex and those containing modified peptides and mutant
Survivin. These studies have defined the importance of peptide
N-terminal Ala1 recognition in both complexes and identified
details of the intermolecular hydrogen-bonding interactions in
the Survivin binding pocket that contribute to H3T3ph mark
recognition. Notably, our calorimetric data establish that
Survivin binds tighter to the H3T3ph-containing peptide relative186 Structure 20, 185–195, January 11, 2012 ª2012 Elsevier Ltd All rto the N-terminal Smac/DIABLO peptide and this preference
can be reversed through structure-guided mutations in the
binding pocket.
During preparation of our paper for submission, Jeyaprakash
et al. (2011) published their structures of human Survivin in
complex with H3T3ph peptide and N-terminal peptide of human
Shugoshin 1.
RESULTS
Overall Structure of Survivin Bound to H3(1-15)T3ph
Peptide
The structure of human Survivin bound to H3(1-15)T3ph was
solved by molecular replacement using the structure of an unli-
ganded Survivin (Protein Data Bank [PDB] code 1F3H; Verdecia
et al., 2000) as a search model and refined to 2.4 A˚ resolution,
yielding R-work of 21.3% and R-free of 25.0% (Table 1). The
overall structure of Survivin in the complex (ribbon representa-
tion in Figure 1A and electrostatic surface representation in
Figure 1B) resembles its structure in the unliganded state
(PDB: 1F3H; Chantalat et al., 2000; Verdecia et al., 2000), with
an rmsd between structures of 0.45 A˚. As anticipated, Survivin
in the complex is composed of an N-terminal BIR domain
(aa 15–89) and a long C-terminal a-helix (aa 100–140), with the
fold stabilized by a Zn2+ ion coordinated by Cys57, Cys60,
His77, and Cys84 (Figure 1A). The asymmetric unit in the
complex (C2 space group) contains two Survivin molecules
that align to form a homodimer (Figure S1 and Supplemental
Materials available online), with the dimer interface formed by
residues 6–10 and 89–102. We can trace N-terminal residues
Ala1 to Gln5 segment of the bound H3(1-15)T3ph peptide in
the structure of the complex (Figures 1A and 1B).
We have also solved the structure of Survivin bound to unmod-
ified H3(1-10) peptide at 2.6 A˚ resolution (Figure S2), with refine-
ment yielding an R-work of 22.2% and R-free of 27.3% (Table 1).
The overall structure of Survivin in the Survivin-H3(1–10)
complex is more similar to the Survivin-H3(1–15)T3ph complex
(rmsd of 0.31 A˚ for 135 aligned Ca atoms) than to Survivin in
the free state (rmsd of 0.48 A˚ for 135 aligned Ca atoms).
We can trace N-terminal residues Ala1 to Lys4 of the bound
H3(1–10) peptide in the structure of the complex.
Recognition of N-terminal H3 A1-R2-T3ph-K4 Segment
by Survivin
We can monitor the first five residues from the N-terminus of
H3(1-15)T3ph and first four residues of H3(1–10) peptides
bound to Survivin in the crystal structures of the complexes
(Figures 1A, 1B, S2A, and S2B). The bound peptides are posi-
tioned in a shallow cleft on the surface of the BIR domain of
Survivin, with the N-terminal Ala1 inserted into a deep nega-
tively charged pocket (Figure 1B). The positively charged
Arg2 and Lys4 residues of the bound peptide are oriented
toward a negatively charged surface (red color, Figure 1B),
whereas the negatively charged T3ph is oriented in the oppo-
site direction toward a positively charged surface (blue color,
Figure 1B).
We initially focus on the intermolecular interactions in the
complex of H3(1–15)T3ph peptide bound to Survivin (stereo
pair in Figure 1C). The N-terminal Ala1 residue is recognized byights reserved
Figure 1. Interactions between H3(1-15)T3ph
Peptide and Survivin in the Complex
(A) Overall interaction between residues Ala1 to Gln5 of
H3(1–15)T3ph peptide and Survivin in the complex. The
bound peptide (yellow) in a stick representation is posi-
tioned within the BIR domain (cyan) of Survivin in a ribbon
representation.
(B) An electrostatics surface representation of Survivin
with bound residues Ala1 to Gln5 of H3(1–15)T3ph
peptide (yellow) in a stick representation. The N-terminus
and Ala1 insert into a negatively charged pocket, the
Arg2 and Lys4 side chains lie on a flat negatively charge
surface, whereas Thr3ph lies on a positively charged
shallow cleft. There is electrostatic complementarity
between the bound H3T3ph peptide and Survivin in the
complex.
(C) Stereo view highlighting details of the intermolecular
interactions between the A1-R2-T3ph-K4 segment of
the bound H3(1–15)T3ph peptide and binding pocket
residues of the BIR domain of Survivin. Intermolecular
hydrogen-bonding interactions are designated by dashed
red lines.
(D) Stereo view of superpositioned structures of un-
liganded Survivin (gray), H3(1–15)T3ph peptide-bound
Survivin (cyan), and H3(1–10) peptide-bound Survivin
(magenta). These views emphasize binding pocket inter-
actions. Note the shift in the a-helix (on left) on complex
formation.
Structure
H3T3ph and SmacN Peptides Recognition by Survivinthe BIR domain of Survivin using recognition principles in com-
mon with those observed for the complex of Smac/DIABLO
peptide bound to the BIR3 domain of XIAP (Liu et al., 2000;
Wu et al., 2000). The N-terminal NH3
+ group of Ala1 of the
bound peptide is anchored through hydrogen-bond formation
with the negatively charged side chains of Asp71 and Glu76,
whereas the carbonyl group of Ala1 forms a hydrogen bond
with the ring nitrogen of His80 (Figure 1C). The side-chain
methyl group of Ala1 inserts into a small hydrophobic pocket
generated by the side chains of Leu64 and Trp67 (Figure 1C).Structure 20, 185–195, January 11The side chain of Arg2 of the bound peptide
forms a hydrogen bond with the side chain of
Glu65, whereas the backbone of Arg2 forms
two main-chain hydrogen bonds in an antipar-
allel b sheet-like manner.
The phosphate group of Thr3ph is positioned
in a positively charged shallow cleft formed
by the side chains of Lys62 and His80. Two of
the three nonbridging phosphate oxygens are
involved in hydrogen-bonding interactions, as
is the bridging phosphate oxygen, with the
acceptors being the ring nitrogen of His80
and the side chain of Lys62 (Figure 1C). The
side chain of Lys4 is positioned between the
side chains of Glu51 and Glu63, with its back-
bone amide forming a main-chain-main-chain
hydrogen bond.
We observe similar intermolecular interac-
tions in the H3(1–10) peptide bound to Survivin,
with the only difference being that unmodifiedThr3 forms a single hydrogen bond between its side chain and
the ring nitrogen of His80 (Figure S2C).
Conformational Transition on Complex Formation
We have superpositioned the structure of Survivin in the free
state (PDB: 1F3H) with the corresponding structures in complex
with H3(1–10) and H3(1–15)T3ph peptides. We note a confor-
mational transition encompassing a segment spanning a long
loop and an a-helix (Pro69 to Gly83), which moves toward the
bound peptide on complex formation (stereo pair in Figure 1D)., 2012 ª2012 Elsevier Ltd All rights reserved 187
Table 2. Summary of Diffraction Data and Structure Refinement
Statistics of SmacN(1–15) Peptide Complexes with Wild-Type
Survivin and Survivin(K62Y/H80W) Double Mutant
Summary of Diffraction Data
Crystal
SmacN(1–15)-
Survivin
SmacN(1–15)-
Survivin(K62Y/H80W)
PDB code 3UIH 3UIJ
Beamline NSLS-X29A APS-24ID-E
Wavelength (A˚) 1.2900 0.9792
Space group C2 C2
Cell parameters
a (A˚) 114.2 114.4
b (A˚) 71.3 71.0
c (A˚) 81.1 82.3
b () 127.5 129.2
Resolution (A˚) 50.0-2.4 (2.49-2.40) 50.0-2.7 (2.80-2.70)
Rmerge (%) 5.9 (59.5) 5.5 (51.2)
Observed reflections 152,848 43,337
Unique reflections 20,178 13,947
Redundancy 7.6 (6.5) 3.1 (3.1)
Average I/s(I) 22.9 (2.6) 23.1 (1.4)
Completeness (%) 98.4 (90.0) 99.4 (97.8)
Refinement and Structure Model
R / R free 20.9 / 24.5 20.5 / 24.2
Number of atoms 2,292 2297
Protein / Peptide 2,212 / 55 2234 / 46
Water 23 15
Zn2+ ion 2 2
Average B factor (A˚2) 86.8 91.8
Protien / Peptide 86.5 / 102.4 91.4 / 121.1
Water 77.8 69.7
Zn2+ ion 76.2 69.5
RMS deviations
Bond lengths (A˚) 0.005 0.004
Bond angles () 0.817 0.728
aValues in parentheses are for highest resolution shell.
Structure
H3T3ph and SmacN Peptides Recognition by SurvivinThis conformational transition makes the BIR domain more
compact on complex formation. In addition, whereas most
residues participating in the interaction with phosphorylated
and unmodified H3 peptides have almost identical conformation
in the two complex structures, the side chain of Lys62 shows
a notable difference. It is directed toward the phosphate of the
bound peptide in the H3(1–15)T3ph-Survivin complex, whereas
being directed away from the bound peptide in the H3(1–10)-
Survivin complex (Figure 1D), consistent with a contributing
role for the side chain of Lys62 in the recognition of the
phosphate.
Recognition of N-terminal A1-V2-P3-I4 Segment of
SmacN Peptide by Survivin
We have also solved the crystal structure of the N-terminal
Smac/DIABLO(1–15) peptide (designated SmacN) bound to Sur-
vivin, with the 2.4 A˚ resolution structure refined to a R-work of188 Structure 20, 185–195, January 11, 2012 ª2012 Elsevier Ltd All r20.9% and a R-free of 24.5% (Table 2). We can trace the
N-terminal A1-V2-P3-I4 segment of the bound peptide in the
complex (Figures 2A and 2B).
TheN-terminal NH3
+ and side chain of Ala1 in theSmacN(1–15)
peptide-Survivin complex are recognized using the same inter-
molecular contacts (stereo view in Figure 2C) as reported above
for the H3(1-15)T3ph peptide-Survivin complex (Figure 1C). The
backbone of Val2 of the bound SmacN peptide forms two
intermolecular hydrogen bonds, involving main-chain-main-
chain interactions in an antiparallel b sheet-like manner (Fig-
ure 2C). The hydrophobic ring of Pro3 of bound SmacN peptide
forms van der Waals contacts with the side chains of Leu64
and His80 (Figure 2C). The segment spanning a long loop and
an a-helix (Pro69 toGly83) alsomoves toward the bound peptide
on formation of this complex (stereo view in Figure 2D).
ITC-based Binding Affinities for Complex Formation
To further characterize the BIR domain of Survivin as a phosho-
recognition domain, we performed pull-downs in vitro with
purified human Survivin. These studies established that
Survivin bound H3 and H3T3ph peptides with similar binding
affinities and the binding was not perturbed by the presence of
histone modifications at R2 (dimethylation), K4 (dimethylation),
K9 (trimethylation), and S10 (phosphorylation; Figure 3A).
We have quantitated the binding parameters for the H3T3ph
peptide bound to Survivin and its binding pocket mutants
by isothermal titration calorimetry (ITC; Figures 3B–3E and
Table 3). We measure a binding affinity of 4.80 mM between
Survivin and H3T3ph peptide (Figure 3B). We observe an
approximately 2-fold drop in binding affinity for the K62A mutant
(10.2 mM), which would disrupt a single hydrogen bond to the
T3ph phosphate, whereas more pronounced drops in binding
affinities are observed for the D71A (150 mM) and E76A (99 mM)
mutants, which would disrupt recognition of the N-terminus,
and the E65A mutant (93 mM), which would disrupt a single
hydrogen bond to the guanidinium group of Arg2 (Table 3). The
binding affinities are significantly reduced for L64A, W67A, and
H80A (all >200 mM and too weak to be measured accurately)
mutants, given that the H80A mutant would disrupt Ala1 recog-
nition, whereas the L64A and W67A mutants would decrease
the stability of the protein, since they are embedded in the inner
part of the protein. Mutation of two other acidic residues, Glu51
and Glu63, which flank the side chain of Lys4, give contrasting
results, with a modest drop for the E51A mutant (14.3 mM) and
a significant drop for the E63A mutant (>200 mM; Table 3).
Unexpectedly, only a modest drop in binding affinity was
observed for Survivin binding to unmodified H3 peptide
(10.0 mM; Figure 3C). Modest drops in binding affinities were
also observed for binding to H3R2me2aT3ph (10.8 mM; Fig-
ure 3D) and H3T3phK4me3 (9.90 mM; Figure 3E) peptides, where
residues on either side of T3ph were modified (Table 3).
Finally, Survivin bound the SmacN peptide with a binding
affinity of 121 mM, which is 25-fold lower than the binding affinity
to the H3T3ph peptide (4.8 mM; Table 3).
Structural Basis for Discrimination between H3T3ph
and SmacN peptides
Our binding data indicate that Survivin binds to H3T3ph peptide
with higher affinity than does the SmacN peptide (Table 3).ights reserved
Figure 2. Interactions between SmacN(1–15)
Peptide and Survivin in the Complex
(A) Overall interaction between residues Ala1 to Ile4 of
SmacN(1–15) peptide and Survivin in the complex. The
bound peptide (yellow) in a stick representation is posi-
tioned within the BIR domain (cyan) of Survivin in a ribbon
representation.
(B) An electrostatics surface representation of Survivin
with bound residues Ala1 to Ile4 of SmacN peptide (yellow)
in a stick representation.
(C) Stereo view highlighting details of the intermolecular
interactions between the A1-V2-P3-I4 segment of the
bound SmacN(1–15) peptide and binding pocket residues
of the BIR domain of Survivin. Intermolecular hydrogen-
bonding interactions are designated by dashed red lines.
(D) Stereo view of superpositioned structures of un-
liganded Survivin (gray) and SmacN peptide-bound
Survivin (cyan). These views emphasize binding pocket
interactions. Note the shift in the a-helix (on left) on
complex formation.
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H3T3ph and SmacN Peptides Recognition by SurvivinAlthough the N-terminal Ala1 of both bound peptides contrib-
utes to recognition in both complexes, there are additional
intermolecular interactions, involving other peptide residues in
the H3T3ph peptide complex (Figure 1C), compared with its
SmacN counterpart (Figure 2C). In efforts to change the speci-
ficity for peptide recognition by Survivin in favor of the SmacN
complex, we introduced K62Y/H80W double mutation in
Survivin, so as to increase the hydrophobic propensity of theStructure 20, 185–195, January 11phosphate-binding pocket. Indeed, the
H3T3ph peptide no longer binds to Survi-
vin(K62Y/H80W) double mutant, whereas the
unmodified H3 peptide binds with unperturbed
binding affinity (10.6 mM; Table 3). By contrast,
SmacN peptide binds a factor of six-fold
tighter to Survivin(K62Y/H80W) double mutant
(19.8 mM; Table 3) when compared to wild-
type Survivin (121 mM; Table 3) as plotted in
Figure 4A.
The crystal structure of the SmacN(1–15)-
Survivin(K62Y/H80W) double mutant complex
(X-ray statistics in Table 2) reveals that the
K62Y/H80W double mutation converts the
positively charged T3ph binding surface from
basic to hydrophobic (Figure 4B), with the large
side chains of tryptophan and tyrosine form
a hydrophobic pocket that readily accommo-
dates the hydrophobic ring of Pro3 of the
SmacN peptide on complex formation (stereo
view in Figure 4C). The loss in binding affinity
for the H3T3ph peptide must reflect both steric
clashes and electrostatic incompatibility within
the binding pocket of the Survivin(K62Y/
H80W) double mutant. By contrast, the H3
peptide, lacking a phosphate at the Thr3 posi-
tion, is readily accommodated in the binding
pocket of the Survivin(K62Y/H80W) doublemutant (X-ray statistics in Table 1) as shown in stereo in
Figure S3.
DISCUSSION
Protein phosphorylation, one of themost common posttranslation
modifications from bacteria to humans, occurs on serine, threo-
nine, histidine, and tyrosine residues. Phosphorylation has the, 2012 ª2012 Elsevier Ltd All rights reserved 189
Figure 3. Pull-down and Isothermal Titra-
tion Calorimetry Measurements of Binding
Affinities between Survivin and H3 Peptides
containing Modifications
(A) A pull-down assay testing binding of human
Survivin to histone H3 containing different modi-
fications. Purified human Survivin (1-142) was
incubated with the indicated peptide beads.
Coomassie staining of input and bead fractions is
shown.
(B) ITC binding curve for complex formation
between H3(1–15)T3ph peptide and Survivin.
(C) ITC binding curve for complex formation
between H3(1–10) peptide and Survivin.
(D) ITC binding curve for complex formation
between H3(1–20)R2me2aT3ph peptide and
Survivin.
(E) ITC binding curve for complex formation be-
tween H3(1–20)T3phK4me3 peptide and Survivin.
Structure
H3T3ph and SmacN Peptides Recognition by Survivinpotential for causing modification-dependent conformational
changeswithin the targetprotein,whilealsochanging its local elec-
trostatics environment. This in turn generates a binding site for
phosphorylation mark-specific binding proteins, thereby medi-190 Structure 20, 185–195, January 11, 2012 ª2012 Elsevier Ltd All rights reservedating signaling pathways. Several domains
are known to bind phosphorylated threo-
nine, including the forkhead-associated
(FHA) domain (Pennell et al., 2010), 14-3-3
(Schumacher et al., 2010; Rajagopalan
et al., 2008), and polo-box domain (Elia
et al., 2003; Yun et al., 2009) proteins.
Although the structures of these three
proteins exhibit considerable diversity,
they use common principles for recogni-
tion, whereby protein surface pockets
can accommodate the phosphorylated
threonine (Figure S4). Individual oxygens
of the phosphate group are coordinated
by positively-charged residues, with the
interactions mediated by a hydrogen-
bonding network. For these proteins, the
phosphate group provides the funda-
mental driving force for phosphorylated
peptide-protein recognition, with the loss
of the phosphate group impacting on
complex formation (Elia et al., 2003; Pen-
nell et al., 2010; Rajagopalan et al., 2008;
Schumacher et al., 2010; Yun et al., 2009).
Structural Basis for Specificity
of H3T3ph Phosphate Group
Recognition
The phosphate group of H3T3ph is posi-
tioned within a positively-charged patch
in Survivin (Figure 1B) and hydrogen
bonded to the side chains of Lys62 and
His80 (Figures 1C), with partial conser-
vation observed for these two residues
among Survivin family members (Fig-
ure S5). Thus, in Schizosaccharomycespombe, which contains two Survivin homologs, one contains
the conserved Lys at position 62, whereas the other does not.
In Xenopus laevis Survivin, His80 is replaced by an Arg, with
this positively charged replacement residue capable of hydrogen
Table 3. Isothermal Titration Calorimetry Binding Assays for H3T3ph Peptide Bound to Survivin and Its Mutants
Protein Peptide N Value Kd (mM) DH (kcal/mol) DS (cal/mol/deg)
Wild-type H3T3ph 0.90 ± 0.03 4.80 ± 1.13 6.13 ± 0.24 3.74
E51A H3T3ph 0.97 ± 0.03 14.3 ± 2.2 6.26 ± 0.26 1.18
K62A H3T3ph 0.84 ± 0.02 10.2 ± 1.0 5.16 ± 0.13 5.52
E63A H3T3ph – NDB – –
L64A H3T3ph – NDB – –
E65A H3T3ph 0.83 ± 0.05 93.4 ± 6.5 4.89 ± 0.35 2.03
W67A H3T3ph – NDB – –
D71A H3T3ph 0.83 ± 0.09 150 ± 13 6.21 ± 0.80 3.33
E76A H3T3ph 0.91 ± 0.06 99.0 ± 9.5 6.40 ± 0.60 3.13
H80A H3T3ph – NDB – –
Wild-type H3 0.86 ± 0.02 10.0 ± 1.4 5.51 ± 0.20 4.38
K62A H3 0.92 ± 0.06 10.8 ± 2.9 7.71 ± 0.64 3.11
Wild-type H3R2me2aT3ph 1.05 ± 0.03 10.8 ± 2.4 6.09 ± 0.30 2.30
Wild-type H3T3phK4me3 0.92 ± 0.03 9.90 ± 1.81 5.69 ± 0.24 3.82
Wild-type SmacN 0.84 ± 0.09 121 ± 15 3.48 ± 0.49 6.24
K62Y/H80W H3T3ph – NDB – –
K62Y/H80W H3 0.85 ± 0.01 10.6 ± 0.7 3.52 ± 0.06 10.9
K62Y/H80W SmacN 0.82 ± 0.02 19.8 ± 2.3 4.44 ± 0.19 6.64
Buffer: 100 mM NaCl, 10 mM HEPES [ pH 7.5], 2 mM b-mercaptoethanol. NDB, no detectable binding.
Structure
H3T3ph and SmacN Peptides Recognition by Survivinbonding with the phosphate group, indicative of a conserved
function associated with recognition of phosphorylated threo-
nine by Survivin homologs. These two residues (Lys62 and
His80) are essential for target recognition in other BIR domains
as well, but their unique pairing in Survivin allows for specific
recognition of H3T3ph.
Unexpectedly, the binding affinity of Survivin for H3T3ph
peptide (Kd = 4.8 mM; Figure 3B) is only 2-fold stronger than it
is for unmodified H3 peptide (Kd = 10.0 mM; Figure 3C), whereas
the K62A mutant of Survivin, which disrupts the hydrogen
bond to H3T3ph (Figure 1C), binds the H3T3ph peptide with
only a 2-fold reduced binding affinity (Kd = 10.2 mM; Table 3).
Since both H3T3ph and H3 peptides differ in their binding
affinities for Survivin by only 2-fold, phosphorylation of T3 is
a contributing factor, but not an absolute requirement, for recog-
nition of N-terminal H3 peptides by Survivin.
Our binding results contrast with the 18-fold preference for
H3T3ph relative to unmodified H3 for recombinant Xenopus
laevis INCENP(1-58)-Survivin-Borealin subcomplex by fluores-
cence anisotropy (Wang et al., 2010). This difference may not
be due to contributions of INCENP and Borealin to recognition,
since the H3T3ph peptide only interacts with the BIR domain
of Survivin without any significant contact with the INCENP
fragment and/or Borealin moieties, following superposition of
our H3T3p-Survivin complex structure with the INCENP-
Survivin-Borealin subcomplex structure (PDB: 2QFA; Jeyapra-
kash et al., 2007; Figure S6), whereas the contribution of the
C-terminal region of Borealin, which is not included in the
structural study, cannot be ruled out.
His80 appears to play a key role in the H3T3ph peptide-
Survivin complex. It forms hydrogen bonds to both bridging
and nonbridging phosphate oxygens of T3ph, as well as the
peptide backbone (Figure 1C). It is therefore not surprising thatStructure 20, 185one observes complete loss of binding affinity for the H80A
mutant (Table 3).
Survivin Predominantly Recognizes N-terminal Ala1
of Bound Peptide
Survivin belongs to the IAP protein family that capitalizes on its
BIR domain for protein recognition (Srinivasula and Ashwell,
2008), mediated by its IAP-binding motif (IBM) containing
tetrapeptide peptide region with a critical N-terminal Ala (Pop
and Salvesen, 2009). The N-terminus of histone H3 and SmacN
peptides do not exhibit much consensus in sequence but do
share the same binding mode by Survivin (Figures 1A and 2A).
The only residue common to the two peptides is Ala at position
1, with the majority of Survivin residues involved in the recogni-
tion of this position strictly conserved from human to yeast,
except for Leu64 and His80, which are relatively conserved
and occasionally replaced by residues with similar properties
in some species (Figure S5). This indicates that other residues
of the peptide may be less critical for recognition by Survivin,
a conclusion consistent with a previous NMR titration experi-
ment against different SmacN derived peptides (Sun et al.,
2005). Nevertheless, Arg2, Thr3ph, and Lys4 of the H3 peptide
exhibit significant interactions with Survivin (Figure 1C), whereas
only Val2 of the SmacN peptide exhibits main-chain-main-chain
interactions (Figure 2C). This disparity in the number of intermo-
lecular interactions could explain the higher binding affinity
between Survivin and H3T3ph peptides (Kd = 4.8 mM) compared
with the SmacN peptide (Kd = 121 mM; Table 3).
The importance of N-terminal recognition of the H3T3ph
peptide by Survivin is attested by the pronounced drop in
binding affinities on mutating Asp71 and Glu76 to Ala (Table 3),
residues involved in intermolecular hydrogen-bond and salt-
bridge formation with the N-terminus (Figure 1C). Similarly, there–195, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 191
Figure 4. Interactions between SmacN(1–15)
Peptide and Survivin (K62Y/H80W) Mutants in the
Complex
(A) ITC binding curves for complex formation between
SmacN(1–15) peptide and wild-type Survivin (red curve)
and Survivin (K62Y/H80W) mutant (blue curve).
(B) An electrostatics surface representation of Survivin
(K62R/H80W) mutant with bound residues A1 to I4 of
SmacN(1–15) peptide (yellow) in a stick representation.
The N-terminus and Ala1 insert into a negatively charged
pocket, while the Pro3 ring lies on a hydrophobic surface
formed by Tyr62 and Trp80.
(C) Stereo view highlighting details of the intermolecular
interactions between the A1-V2-P3-I4 segment of the
bound SmacN(–15) peptide and binding pocket residues
of the BIR domain of Survivin (K62R/H80W) mutant.
Intermolecular hydrogen-bonding interactions are desig-
nated by dashed red lines.
See also Figure S3.
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and His80 to Ala in Survivin (Table 3), residues that contact
the methyl group of Ala1 (Figure 1C) and are also most likely
important for formation of the hydrophobic core of the BIR
domain.
Impact of Histone Modifications Adjacent
to H3T3ph Site
The side chains of Arg2 and Lys4 are directed toward an acidic
patch on Survivin; hence, we anticipated that H3T3ph recogni-
tion by Survivin could be measurably impacted by methylation
of adjacent Arg2 and Lys4 within the H3 A1-R2-T3ph-K4 se-
quence context. Instead, the binding affinities were reduced
by only approximately 2-fold for both the dual H3R2me2aT3ph
(Kd = 10.8 mM; Table 3 and Figure 3) and the dual H3T3phK4me3
(Kd = 9.9 mM; Table 3 and Figure 3) modifications. There is room
in our structure of the complex (Figure 1C) to accommodate
methyl groups on both Arg2 and Lys4, thereby explaining the
modest decrease in binding affinities. Our results contrast with
a pull-down assay, involving mitotic HeLa cell lysate, in which
trimethylation of Lys4 adjacent to Thr3ph resulted in a strong
diminishment of the interaction between CPC complex and
histone peptide (Wang et al., 2010).
Peptide Discrimination by Survivin Binding Pocket
Our binding and structural studies on H3 and SmacN peptide
binding to Survivin and its binding pocket mutants have provided
insights into the factors contributing to molecular recognition.192 Structure 20, 185–195, January 11, 2012 ª2012 Elsevier Ltd All rights reservedIn addition to the contribution of N-terminal
Ala1 to recognition, peptide position 3 and the
residues that it interacts with in the binding
pocket of Survivin, also contribute to recogni-
tion. Indeed, our studies establish that the
observed 25-fold preference for H3T3ph
peptide over SmacN peptide by wild-type
Survivin (Table 3), reflecting a basic patch in
the pocket that favors the negatively charged
phosphate of T3ph, can be reversed in favor of
SmacN peptide following incorporation ofK62Y/H80W double mutation in the binding pocket of Survivin,
which on forming a hydrophobic cage, favors Pro3 over the
charged and bulky T3ph (Table 3). By contrast, there is no impact
on the binding affinity for Thr at position 3, which binds with
unchanged affinity to both wild-type and K62Y/H80W double
mutant of Survivin (Table 3).
Our thermodynamic characterization of the interaction of
Survivin and Survivin mutants with target peptides has demon-
strated that the interaction of H3 peptides with or without phos-
phorylated Thr3 have comparable binding affinities. This must
reflect a complex binding mode, whereby each residue within
the ARTK motif of the H3 peptide makes distinct contributions.
The repression of Haspin function has quite dramatic cellular
effects and leads to a substantial depletion of the CPC from
the centromere, an observation that contrasts with the compa-
rable binding affinities of Survivin for H3T3ph and H3 peptides
in the present. We conclude that our current structural under-
standing of this interaction might be insufficient for a full account
of the role of Thr3 in CPC recruitment.
Comparison with a Related Contribution on Structures
of Survivin Complexes
During preparation of our paper for submission, another group
published their structures of human Survivin in complex with
H3T3ph peptide and N-terminal peptide of human Shugoshin
1 (Jeyaprakash et al., 2011). The structures of Survivin-
H3T3ph peptide complexes reported by Jeyaprakash et al.
(2011) and our group are almost identical, with both groups
Structure
H3T3ph and SmacN Peptides Recognition by Survivinusing structural and biochemical data to investigate the princi-
ples underlying binding specificity. In addition, our group also
studied the binding between Survivin and unmodified H3
peptide and with its Smac/DIABLO binding partner. These
studies highlight that the binding is dependent on Ala1,
together with a preference for the third position of the peptide,
which is further confirmed by an engineered mutant that
reverses the binding specificity. Our studies of Survivin
complexes with both H3T3ph and Smac/DIABLO peptides
provide a plausible connection between apoptosis and mitosis
by Survivin. The studies by Jeyaprakash et al. (2011) focused
on the structural role of Survivin in mitosis. They identified
a potential putative Survivin-binding epitope and showed that
Surivin can also bind to human Shugoshin 1 in vitro, thereby
raising the possibility that Survivin engages in mutually exclu-
sive interactions with other cell cycle machinery proteins in
mitosis (Jeyaprakash et al., 2011).
Conclusions
The research presented here defines the structural relationship
between the BIR domain of human Survivin and the N-terminal
tails of histone H3 and Smac/DIABLO peptides. Unexpectedly,
phosphorylation of Thr3 on the histone H3 tail does not sig-
nificantly enhance binding to human Survivin in vitro. Our
structure-function data indicate that Survivin engages H3 and
H3T3ph utilizing the same residues, which led to the identifica-
tion of Survivin(K62Y/H80W) double mutant that blocks binding
to H3T3ph but not H3. The interaction of human Survivin with
Smac/DIABLO utilizes the same binding pocket as histone H3,
suggesting that Survivin has physiological targets other than
histone H3T3ph depending on the cellular context.
EXPERIMENTAL PROCEDURES
Protein Preparation
The gene-encoding full-length human Survivin was purchased from Open
Biosystems (Lafayette, CO, USA) and was inserted into a self-modified vector,
which fuses an N-terminal hexa-histidine plus yeast Sumo tag to the target
gene. The fusion protein was expressed in E. coli strain BL21 (DE3) RIL
(Stratagene, Santa Clara, CA, USA). The cells were cultured at 37C until
OD600 reached 1.0, following which the media was cooled to 20
C and IPTG
wasadded toa final concentrationof 0.2mMto induceprotein expressionover-
night. Thecellswere harvestedbycentrifugeat 4Canddisruptedbysonication
in buffer A (500 mM NaCl, 20 mM imidazole, and 50 mM Tris [pH 8.0]) supple-
mented with 1 mM PMSF and 2 mM b-mercaptoethanol. After centrifugation,
the supernatant was loaded onto a HisTrap FF column (GE Healthcare, Little
Chalfont, Buckinghamshire, UK). After extensivewashingbybuffer A, the target
protein was eluted with buffer A supplemented with 300 mM imidazole. The
hexa-histidine-Sumo tagwascleavedbyUlp1protease and removedby further
passing through a HisTrap FF column. The pooled target protein was further
purified by a Hiload Superdex G75 26/60 column (GE Healthcare) with buffer
B (150 mM NaCl, 20 mM Tris [pH 8.0], and 5 mM DTT). All the mutants were
constructed using a QuikChange Mutagenesis Kit (Stratagene) and purified
with the same protocol as the wild-type protein. The unmodified H3(1–10),
unmodified H3(1–15), H3(1–15)T3ph, and SmacN(1–15) peptides were
synthesized by the Tufts University peptide synthesis facility (Medford, MA,
USA). The peptides H3(1–21)R2me2aT3ph, H3T3phK9me3, H3K9me3,
H3T3phK9me3S10ph, and H3(1–21)T3phK4me3 were ordered from the
Rockefeller University Proteomics Resource Center (New York, NY, USA).
Crystallization and Synchrotron Data Collection
For crystallization of Survivin complexes with different peptides, the Survivin
protein was concentrated to 15 mg/ml and mixed with peptides in molarStructure 20, 185ratios of 1:2 at 4C for 1 hr. Crystallization was carried out at 20C using
the hanging drop vapor diffusion method by mixing 1 ml protein-peptide
complex sample with 1 ml reservoir solution and equilibrated against 0.4 ml
reservoir. Several conditions yielded crystallization of the complexes within
2 days. The best crystals of H3(1–15)T3ph-Survivin complex grew under
conditions containing 0.1 M DL-malic acid (pH 7.0), 12% PEG 3350, whereas
those of H3(1–10)-Survivin complex grew under conditions of 0.1 M
ammonium citrate tribasic (pH 7.0), 12% PEG 3350. The best crystals of
SmacN(1–15)-Survivin complex grew under conditions of 0.2 M potassium
thiocyanate, 10% PEG 3350, whereas those of of SmacN(1-15)-Survivin
K62Y/H80W mutant complex grew under conditions of 0.2 M sodium
bromide, 12% PEG 3350. The best crystals of H3(1–10)-Survivin K62Y/
H80W mutant complex grew under conditions of 0.2 M succinic acid
(pH 7.0), 12% PEG 3350. All crystals were dehydrated by soaking into the
corresponding reservoir solution that was supplemented with 20% glycerol
for 2 min. Then the crystals were directly mounted on a nylon loop for diffrac-
tion data collection.
The data for H3(1-15)T3ph-Survivin complex were collected at NE-CAT
beamline 24ID-C, Advanced Photon Source (APS) at Argonne National
Laboratory (Chicago, IL, USA). The data for H3(1-10)-Survivin complex,
SmacN(1–15)-Survivin K62Y/H80W mutant complex, and H3(1–10)-Survivin
K62Y/H80W mutant complex were collected at APS beamline 24ID-E. The
data for SmacN(1–15)-Survivin complex were collected at beamline X29A,
National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory
(New York, NY, USA). All the data were processed with the program
HKL2000 (Otwinowski and Minor, 1997). The statistics of the diffraction data
are summarized in Tables 1 and 2.Structure Determination and Refinement
All of the structures of the complexes were solved using the molecular
replacement method implemented in the program Phenix (Adams et al.,
2010), using the structure of unliganded Survivin (PDB code 1F3H; Verdecia
et al., 2000) as the search model. The model building was carried out using
the program Coot (Emsley et al., 2010) and structural refinement carried out
using the program Phenix (Adams et al., 2010) with TLS parameters generated
by the TLS Motion Determination server (Painter and Merritt, 2006). Free
R-factor was calculated using 5% random chosen reflections. For the H3(1–
15)T3ph-Survivin complex, the peptide had a well-defined electron density
and peptide residues from Ala1 to Gln5 were traced without ambiguity (Fig-
ure S7A). For the H3(1–10)-Survivin complex, the main chain of peptide from
Ala1 to Lys4 could be well traced but some of the side chains exhibited poor
density (Figure S7B). For the SmacN-Survivin complex, residues from Ala1
and Ile4 could be traced without ambiguity (Figure S7C). The stereochemistry
of the structures were analyzed using the program Procheck (Laskowski et al.,
1993). A summary of diffraction data and structure refinement statistics are
listed in Tables 1 and 2. All molecular graphics were generated with the
program Pymol (DeLano Scientific LLC, http://www.pymol.org/). Sequences
were aligned using the program ClustalX (Larkin et al., 2007) and illustrated
using the ESPript server (Gouet et al., 1999).Pull-downs and Isothermal Titration Calorimetry Binding Assays
For pull-downs with purified proteins, High Capacity Streptavidin Agarose
(Thermo Scientific, LaFayette, CO, USA) was used. After washing beads three
times in binding/wash buffer (20 mM Tris-Cl [pH 7.6], 150 mM NaCl, 0.1%
Triton X-100, and 0.1mM TCEP), they were incubated with 0.4 nmol of peptide
per ml of beads for 2 hr at room temperature. Ten microliter of beads (1 nmol
peptide) were washed three times, and 100 ml of protein mixture (1 uM) in
binding/wash buffer was incubated with beads for three hours at 4C, washed
four times, and eluted with 2X SDS sample buffer and gels stained with
Coomassie R-250.
All the binding experiments were performed on a Microcal calorimeter ITC
200 instrument at 25C. First, wild-type and mutant Survivin protein samples
were dialyzed for 3 hr against buffer C (100 mM NaCl, 2 mM b-mercaptoetha-
nol, and 20 mM HEPES [pH 7.5]) at room temperature. Then, the protein
samples were dilutedwith buffer C and the lyophilized peptideswere dissolved
in buffer C. The titration was according to standard protocol and the data were
fit using the program Origin 7.0 with a 1:1 binding model.–195, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 193
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